期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Toll样受体激动剂研究进展 被引量：4

原文传递
导出
摘要 Toll样受体(TLRs)在机体防御反应中的重要作用已经被多数人所认识,而通过TLRs激动剂来调节免疫反应以达到预防和治疗疾病的目的,则成为近几年新的研究热点。本文就TLRs激动剂的应用研究进展作一综述。
作者 车金辉 嵇武
机构地区 南京大学医学院临床学院(南京军区南京总医院)解放军普通外科研究所
出处 《江苏医药》 CAS CSCD 北大核心 2012年第7期834-836,共3页 Jiangsu Medical Journal
基金 江苏省自然科学基金课题(BK2008327)
关键词 TOLL样受体 受体激动剂 机体防御反应 调节免疫反应 TLRS
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献16

  • 1嵇武,李宁.Toll样受体与临床疾病关系的研究进展[J].中国误诊学杂志,2007,7(16):3709-3711. 被引量：7
  • 2Parker LC,Pr ince LR,Sabroe I.Translational mini-reviewSeries on Toll-like receptors:networks regulated by Toll-likereceptors mediate innate and adaptive immunity[J].Clin ExpImmunol,2007,147(2):199-207.
  • 3李光照,杭春华.Toll样受体在脑损伤中的作用机制和研究进展[J].医学研究生学报,2010,23(12):1319-1323. 被引量：7
  • 4Engel AL,Holt GE,Lu H.The pharmacokinetics of Toll-likereceptor agonists and the impact on the immune system[J].Expert Rev Clin Pharmacol,2011,4(2):275-289.
  • 5Zeromski J,Mozer-Lisewska I,Kaczmarek M.Significance oftoll-like receptors expression in tumor growth and spreading:a short review[J].Cancer Microenviron,2008,1(1):37-42.
  • 6Michelsen KS,Arditi M.Toll-like receptors and innateimmunity in gut homeost asis and pathology[J].Curr OpinHematol,2007,14(1):48-54.
  • 7Zapata JM,Llobet D,Krajewska M,et al.Lymphocyte-specificTRAF3transgenic mice have enhanced humoral responsesand develop plasmacytosis,autoimmunity,inflammation,andcancer[J].Blood,2009,113(19):4595-4603.
  • 8Sado T,Naruse K,Noguchi T,et al.Inflammatory patternrecognition receptors and their ligands:factors contributing tothe pathogenesis of preeclampsia[J].Inflamm Res,2011,60(6):509-520.
  • 9Valins W,Amini S,Berman B.The expression of Toll-likereceptors in dermatological diseases and the therapeutic effectof current and newer topical Toll-like receptor modulators[J].J Clin Aesthet Dermatol,2010,3(9):20-29.
  • 10Kanzler H,Barrat FJ,Hessel EM,et al.Therapeutic targe-ting of innate immunity with Toll-like receptor agonists andantagonists[J].Nat Med,2007,13(5):552-559.

二级参考文献16

  • 1AN HuaZhang,QIAN Cheng & CAO XueTao National Key Laboratory of Medical Immunology & Institute of Immunology,Second Military Medical University,Shanghai 200433,China.Regulation of Toll-like receptor signaling in innate immunity[J].Science China(Life Sciences),2010,53(1):34-43. 被引量：29
  • 2陈新忠,孙宗全,杜心灵,柳祎,吴龙,刘超,陈家军.单核细胞Toll样受体4可能介导热休克蛋白70信号的转导[J].中华医学杂志,2005,85(7):483-486. 被引量：17
  • 3Gibson FC,Yumoto H,Takahashi Y,et al.Innate immune signaling and porphyromonas gingivalis-accelerated atherosclerosis[J].J dent Res,2006,85(2):106-121.
  • 4Cario E,Podolsky DK.Toll-like receptor signaling and its relevance to intestinal inflammation[J].Ann N Y Acad Sci,2006,1072:332-338.
  • 5Goepfert AR,Varner M,Ward K,et al.Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy[J].Am J Obstet Gynecol,2005,193 (4):1478-1485.
  • 6Lin Y,Zeng Y,Zeng S,et al.Potential role of toll-like receptor 3 in a murine model of polyinosinic-polycytidylic acid-induced embryo resorption[J].Fertil-Steril,2006,85(Suppl 1):1125-1129.
  • 7Thornley TB,Brehm MA,Markees TG,et al.TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts[J].J Immunal,2006,176(3):1561-1570.
  • 8Obhrai J,Goldstein DR.The roll of toll-like receptors in solid organ transplantation[J].Transplantation,2006,81(4):497-502.
  • 9Romagne F.Current and future drugs targeting one class of innate immunity receptors:the Toll-like receptors[J].Drug Discov Today,2007,12(1-2):80-87.
  • 10Ishihara S,Rumi MA,Ortega-Cava CF,et al.Therapeutic targeting of toll-like receptors in gastrointestinal inflammation[J].Curr Pharm Des,2006,12(32):4215-4228.

共引文献12

同被引文献36

  • 1丁亮华,罗光华,董选.成人骨髓基质干细胞体外诱导成骨细胞[J].江苏医药,2005,31(2):84-86. 被引量：8
  • 2喻本桐,马燕琳,刘季春,万于华,徐华.成人骨髓间充质干细胞多向分化潜能特性[J].江苏医药,2007,33(7):686-687. 被引量：3
  • 3Glass GE,Chan JK,Freidin A,et al.TNF-αpromotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells[J].Proc Natl Acad Sci USA,2011,108(4):1585-1590.
  • 4Mountziaris PM,Mikos AG.Modulation of the inflammatory response for enhanced bone tissue regeneration[J].Tissue Eng Part B Rev,2008,14(2):179-186.
  • 5Raicevic G,Najar M,Pieters K,et al.Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin[J].Tissue Eng Part A,2012,18(13-14):1410-1418.
  • 6Wennberg C,Hessle L,Lundberg P,et al.Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice[J].J Bone Miner Res,2000,15(10):1879-1888.
  • 7Densmore JC,Signorino PR,Ou J,et al.Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury[J].Shock,2006,26(5):464-471.
  • 8Peek RM Jr, Crabtree JE. Helicobacter infection and gastric neopla- sia[J]. J Pathol, 2006, 208:233-248.
  • 9Rothmeier AS, Ruf W. Protease-activated receptor 2 signaling in inflammation[J]. Semin Immunopathol, 2012, 34:133-149.
  • 10Seo JH, Lim JW, Yoon JH, et al. Proteinase-Activated Receptor-2 Mediates the Expression of Integrin alpha5 and betal in Helieo- baeter pylori-Infected Gastric Epithelial AGS Cells[J]. Digestion, 2009, 80:40-49.

引证文献4

二级引证文献4

江苏医药
2012年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部